HEALTHX305.00

Health X Platform Limited

· Pharma & Health
₹ CrorePeersSURAKSHAKRSNAANEPHROPLUS3BBLACKBIOMcap ₹970 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Returns
Return on Common Equity0.89-10.550.150.15
Return on Assets0.51-13.71-0.15-0.15
Margins
EBITDA Margin0.39-5.04-3.95-4.53
Operating Margin-0.27-5.57-4.45-4.45
Incremental Operating Margin21.961.51
Pretax Margin4.05-17.36-0.18-2.08
Net Income Margin0.43-12.02-0.11-1.78
Net Income to Common Margin0.65-8.210.09-1.38
FCF Margin1.74-2.49-6.73-6.73
Additional
Effective Tax Rate-65.2936.3638.6114.78
Sustainable Growth Rate0.89-10.550.150.15
Incremental Operating Margin %21.961.51-10.21
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.